SAN DIEGO, June 23, 2014 (GLOBE NEWSWIRE) — HempMeds™ proudly announces its participation in and sponsorship of the Cannabis Business Summit hosted by the National Cannabis Industry Association in Denver. The conference takes place on June 24-25 at the Convention Center. The NCIA‘s mission is protecting legitimate cannabis businesses, banking access for those businesses, and fair tax policy. There will be a wide variety of presentations from industry leaders; HempMeds is sponsoring a networking session on June 24.
“A major challenge that cannabis-based businesses face is being treated like any other business would,” states Andrew Hard, Director of Public Relations for HempMeds™. “We support the efforts of the NCIA and feel that as the industry evolves, fair taxation and banking regulations must be addressed. There will be an estimated 800 business owners and professionals attending the Cannabis Business Summit. That is a very good indication that the stigma once surrounding cannabis-based businesses is being eliminated, new businesses are sprouting up, and industry growth will dictate the full acceptance of cannabis-based businesses in the U.S.”
“HempMeds™ is proud to be a leading hemp-based business featured at the Cannabis Business Summit,” Hard continues. “At the conference we will address the Company’s opinion that CBD-only legislation is not prudent, as it does not allow access to the ‘whole plant.’ However, for states that have not or will not legalize cannabis, CBD-rich hemp oil products are a readily available option to try. The Company feels that trying CBD-rich hemp oil products first should be a major consideration for individuals and families prior to relocating to a legalized state. HempMeds appreciates the NCIA for creating a platform for these types of policy discussions to take place.”
Members of the media wishing to attend and cover the conference should contact Andrew Hard, Director of Public Relations at HempMeds, for media passes. If by phone, call 917.660.5418 or email to Andrew.Hard@hempmeds.com.
For more information on CBD-rich hemp oil products, please visit:
HempMeds™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Andrew Hard Director of PR, HempMeds